Skip to main content

Plaintiffs Fight Against The Mass Removal Of Talc Lawsuit

Plaintiffs Fight Against The Mass Removal Of Talc Lawsuit

Plaintiffs Fight Against The Mass Removal Of Talc Lawsuit

Introduction

Johnson & Johnson faced opposition from plaintiffs attorneys to push back against the mass removal of their cases from state to federal court following the bankruptcy filed by Imerys Inc., J&J’s major talc supplier. The lawyers represent hundreds of women who allege talcum powder caused their ovarian cancer.

Nancy Winkler of Eisenberg Rothweiler Winkler Eisenberg & Jeck is representing several plaintiffs. In one of the cases handled by Winkler for Ellen Kleiner, the trial was cleared to be Philadelphia’s first trial over the alleged link between talc and ovarian cancer, but the case was removed in April, for the second time, to federal court in Pennsylvania. Winkler filed a motion for remand and said she is preparing to try the case in Philadelphia state court in early 2020.

Nearly 14,000 talcum powder lawsuits are filed against J&J, each raising a common allegation that asbestos exposure from the company’s talc-based products causes ovarian cancer or mesothelioma. Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. overlooks J&J's talcum powder multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) in the District of New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Links Roundup Chemical to Long-Term Brain Damage

Categories: Roundup

A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…

Zimmer Biomet Gets FDA Approval for Cementless Partial Knee

Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!